Director, MEG Lead Hematology, Medical Evidence Generation at Bristol Myers Squibb

The Director, MEG Lead Hematology, Medical Evidence Generation at Bristol Myers Squibb is responsible for overseeing and driving the generation of medical evidence within the Hematology therapeutic area. This involves managing various types of studies, including Clinical Research Collaborations (CRCs), Medical Affairs Sponsored Studies (MAST), and Investigator-Sponsored Research Studies (ISRs). The role requires ensuring these evidence generation efforts align with internal strategies to support and accelerate pipeline development. The position focuses on fostering strong relationships with external thought leaders and academic institutions to identify and address critical evidence gaps. The MEG Lead will manage the entire lifecycle of research studies, from initial concept ideation through governance approval and execution. This includes serving as a key point of contact for internal therapeutic and disease area teams, facilitating scientific dialogue, and representing Bristol Myers Squibb as a reliable and innovative partner in the scientific community.